Showing results (171-180 of 1,902) with videos related to
Sort By:
Pageof 191
Leukemia & Lymphoma|September 24, 1999
Phase I study of arabinosyl-5-azacytidine (fazarabine) in adult acute leukemia and chronic myelogenous leukemia in blastic phaseM Wilhelm, S O'Brien, M B Rios, et al.Cancer|October 1, 1993
Fludarabine and cytosine arabinoside in the treatment of refractory or relapsed acute lymphocytic leukemiaS Suki, H Kantarjian, V Gandhi, et al.Cancer|January 28, 1999
Complete hematologic and cytogenetic response to 2-amino-9-beta-D-arabinosyl-6-methoxy-9H-guanine in a patient with chronic myelogenous leukemia in T-cell blastic phase: a case report and review of the literatureA Aguayo, J E Cortes, H M Kantarjian, et al.Journal of the American Academy of Dermatology|November 27, 2002
A nonfatal case and 2 fatal cases of paraneoplastic pemphigus: can a complement indirect immunofluorescent test help to identify fatal "group A" paraneoplastic pemphigus cases?Ernst H Beutner, Stephen Pelton, Takashi Hashimoto, et al.Leukemia & Lymphoma|May 1, 1993
High-dose cytosine arabinoside in chronic lymphocytic leukemia: a clinical and pharmacologic analysisL E Robertson, R Hall, M J Keating, et al.Cancer Chemotherapy and Pharmacology|December 29, 2000
Phase II trial and pharmacokinetic evaluation of cytosine arabinoside for leptomeningeal metastases from breast cancerF J Esteva, L T Soh, F A Holmes, et al.Leukemia|September 1, 1995
A 3-day schedule of fludarabine in previously treated chronic lymphocytic leukemiaL E Robertson, S O'Brien, H Kantarjian, et al.Annals of Oncology : Official Journal of the European Society for Medical Oncology|January 1, 1994
Fludarabine--present status and future developments in chronic lymphocytic leukemia and lymphomaM J Keating, P McLaughlin, W Plunkett, et al.The Journal of Biological Chemistry|January 5, 2000
Nucleotide requirements for the in vitro activation of the apoptosis protein-activating factor-1-mediated caspase pathwayD Genini, I Budihardjo, W Plunkett, et al.Pharmacotherapy|October 18, 2000
Pharmacokinetics of gemcitabine and 2',2'-difluorodeoxyuridine in a patient with ascitesB J Delauter, R K Ramanathan, M J Egorin, et al.Pageof 191